1. Home
  2. JAGX vs ASNS Comparison

JAGX vs ASNS Comparison

Compare JAGX & ASNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAGX
  • ASNS
  • Stock Information
  • Founded
  • JAGX 2013
  • ASNS 1998
  • Country
  • JAGX United States
  • ASNS United States
  • Employees
  • JAGX N/A
  • ASNS N/A
  • Industry
  • JAGX Biotechnology: Pharmaceutical Preparations
  • ASNS Telecommunications Equipment
  • Sector
  • JAGX Health Care
  • ASNS Telecommunications
  • Exchange
  • JAGX Nasdaq
  • ASNS Nasdaq
  • Market Cap
  • JAGX 7.4M
  • ASNS 6.1M
  • IPO Year
  • JAGX N/A
  • ASNS 2022
  • Fundamental
  • Price
  • JAGX $4.06
  • ASNS $0.71
  • Analyst Decision
  • JAGX Strong Buy
  • ASNS Strong Buy
  • Analyst Count
  • JAGX 1
  • ASNS 1
  • Target Price
  • JAGX $60.00
  • ASNS $5.00
  • AVG Volume (30 Days)
  • JAGX 108.8K
  • ASNS 348.2K
  • Earning Date
  • JAGX 05-15-2025
  • ASNS 05-13-2025
  • Dividend Yield
  • JAGX N/A
  • ASNS N/A
  • EPS Growth
  • JAGX N/A
  • ASNS N/A
  • EPS
  • JAGX N/A
  • ASNS N/A
  • Revenue
  • JAGX $11,552,000.00
  • ASNS $7,755,000.00
  • Revenue This Year
  • JAGX $22.41
  • ASNS N/A
  • Revenue Next Year
  • JAGX $30.00
  • ASNS $104.77
  • P/E Ratio
  • JAGX N/A
  • ASNS N/A
  • Revenue Growth
  • JAGX 13.93
  • ASNS 72.95
  • 52 Week Low
  • JAGX $3.75
  • ASNS $0.53
  • 52 Week High
  • JAGX $110.75
  • ASNS $2.73
  • Technical
  • Relative Strength Index (RSI)
  • JAGX 33.50
  • ASNS 48.69
  • Support Level
  • JAGX $4.27
  • ASNS $0.66
  • Resistance Level
  • JAGX $4.90
  • ASNS $0.77
  • Average True Range (ATR)
  • JAGX 0.49
  • ASNS 0.06
  • MACD
  • JAGX -0.04
  • ASNS 0.00
  • Stochastic Oscillator
  • JAGX 9.27
  • ASNS 55.71

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About ASNS Actelis Networks Inc.

Actelis Networks Inc is a networking solutions company with a mission to enable communication for Internet of Things, or IoT, projects, deployed over wide areas such as cities, campuses, airports, military bases, roads, and rail. Its networking solutions use a combination of newly deployed fiber infrastructure and existing copper and coaxial lines to create a cost-effective, secure, and quick-to-deploy network. Its solutions also offer end-to-end network security to protect critical IoT data, utilizing a powerful combination of coding and encryption technologies, applied as required on both new and existing infrastructure within the hybrid-fiber-copper network. The company operates as one operating segment: developing and marketing access broadband equipment for copper and fiber networks.

Share on Social Networks: